The structures of Fra-2 and Fra-1 are very similar, and the opposite effect of the two in the same disease is also worth thinking and studying, and both are considered to be therapeutic targets for pulmonary fibrosis. This evidence concerns the gene FOSL1 and pulmonary fibrosis.